The NCI Community Oncology Research Program (NCORP) is a national network of cancer care investigators, providers, academia, and other organizations that care for diverse populations in health systems.
The DCP Community Oncology and Prevention Trials Research Group administers this program.
On this page
About NCORP
The program brings cancer clinical trials and control and delivery studies to individuals in their own communities, thereby generating a broadly applicable evidence base that contributes to improved patient outcomes and a reduction in cancer disparities.
Grantee Details
No matching Grants were found.
Clinical Trials
Title Sort descending | Intervention | Sponsor | Status |
---|---|---|---|
Breast-Conserving Surgery and Radiation Therapy in Patients With Multiple Ipsilateral Breast Cancer | therapeutic conventional surgery, whole breast irradiation | Alliance for Clinical Trials in Oncology | Completed |
Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy | Brief Behavioral Therapy, Educational Intervention, Telephone-Based Intervention | Gary Morrow | Completed |
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer | Bupropion 150 mg XL, Placebo | NRG Oncology | Completed |
Bupropion to Reduce Cancer Related Fatigue in Cancer Survivors | Bupropion Hydrochloride Controlled-release, Placebo Administration, Quality-of-Life Assessment, Questionnaire Administration | University of Rochester NCORP Research Base | Recruiting |
CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells | Cytology Specimen Collection Procedure, Laboratory Biomarker Analysis | GOG Foundation | Active, not recruiting |
Cancer and Blood Pressure Management, CARISMA Study | Best Practice, Blood Pressure Measurement, Clinical Management, Quality-of-Life Assessment, Questionnaire Administration | ECOG-ACRIN Cancer Research Group | Active, not recruiting |
Cancer Care Delivery in Adolescent and Young Adult Patients With Acute Lymphoblastic Leukemia | Discussion, Medical Chart Review, Questionnaire Administration | Children's Oncology Group | Active, not recruiting |
Carvedilol in Preventing Heart Failure in Childhood Cancer Survivors | Carvedilol, Laboratory Biomarker Analysis, Pharmacogenomic Study, Pharmacological Study, Placebo Administration, Quality-of-Life Assessment, Questionnaire Administration | Children's Oncology Group | Active, not recruiting |
Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant | Caspofungin Acetate, Fluconazole, Laboratory Biomarker Analysis, Voriconazole | Children's Oncology Group | Completed |
Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia | Caspofungin Acetate, Fluconazole, Laboratory Biomarker Analysis | Children's Oncology Group | Completed |